These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
144 related articles for article (PubMed ID: 31408970)
1. Hepatic Resection Following Selective Internal Radiation Therapy for Colorectal Cancer Metastases in the FOXFIRE Clinical Trial: Clinical Outcomes and Distribution of Microspheres. Winter H; Rassam J; Virdee PS; Goldin R; Pitcheshwar P; Weaver K; Primrose J; Berry DP; Wasan HS; Sharma RA Cancers (Basel); 2019 Aug; 11(8):. PubMed ID: 31408970 [TBL] [Abstract][Full Text] [Related]
2. FOXFIRE protocol: an open-label, randomised, phase III trial of 5-fluorouracil, oxaliplatin and folinic acid (OxMdG) with or without interventional Selective Internal Radiation Therapy (SIRT) as first-line treatment for patients with unresectable liver-only or liver-dominant metastatic colorectal cancer. Dutton SJ; Kenealy N; Love SB; Wasan HS; Sharma RA; BMC Cancer; 2014 Jul; 14():497. PubMed ID: 25011439 [TBL] [Abstract][Full Text] [Related]
3. Protocol for Combined Analysis of FOXFIRE, SIRFLOX, and FOXFIRE-Global Randomized Phase III Trials of Chemotherapy +/- Selective Internal Radiation Therapy as First-Line Treatment for Patients With Metastatic Colorectal Cancer. Virdee PS; Moschandreas J; Gebski V; Love SB; Francis EA; Wasan HS; van Hazel G; Gibbs P; Sharma RA JMIR Res Protoc; 2017 Mar; 6(3):e43. PubMed ID: 28351831 [TBL] [Abstract][Full Text] [Related]
4. Selective Internal Radiation Therapy (SIRT) with yttrium-90 resin microspheres plus standard systemic chemotherapy regimen of FOLFOX versus FOLFOX alone as first-line treatment of non-resectable liver metastases from colorectal cancer: the SIRFLOX study. Gibbs P; Gebski V; Van Buskirk M; Thurston K; Cade DN; Van Hazel GA; BMC Cancer; 2014 Dec; 14():897. PubMed ID: 25487708 [TBL] [Abstract][Full Text] [Related]
5. Liver Resection for Colorectal Hepatic Metastases after Systemic Chemotherapy and Selective Internal Radiation Therapy with Yttrium-90 Microspheres: A Systematic Review. Baltatzis M; Siriwardena AK Dig Surg; 2019; 36(4):273-280. PubMed ID: 29886488 [TBL] [Abstract][Full Text] [Related]
7. Quality of life in the FOXFIRE, SIRFLOX and FOXFIRE-global randomised trials of selective internal radiotherapy for metastatic colorectal cancer. Wolstenholme J; Fusco F; Gray AM; Moschandreas J; Virdee PS; Love S; Van Hazel G; Gibbs P; Wasan HS; Sharma RA Int J Cancer; 2020 Aug; 147(4):1078-1085. PubMed ID: 31840815 [TBL] [Abstract][Full Text] [Related]
8. Effect of Primary Tumor Side on Survival Outcomes in Untreated Patients With Metastatic Colorectal Cancer When Selective Internal Radiation Therapy Is Added to Chemotherapy: Combined Analysis of Two Randomized Controlled Studies. Gibbs P; Heinemann V; Sharma NK; Taieb J; Ricke J; Peeters M; Findlay M; Robinson B; Jackson C; Strickland A; Gebski V; Van Buskirk M; Zhao H; van Hazel G; Clin Colorectal Cancer; 2018 Dec; 17(4):e617-e629. PubMed ID: 30033117 [TBL] [Abstract][Full Text] [Related]
9. SIRFLOX: Randomized Phase III Trial Comparing First-Line mFOLFOX6 (Plus or Minus Bevacizumab) Versus mFOLFOX6 (Plus or Minus Bevacizumab) Plus Selective Internal Radiation Therapy in Patients With Metastatic Colorectal Cancer. van Hazel GA; Heinemann V; Sharma NK; Findlay MP; Ricke J; Peeters M; Perez D; Robinson BA; Strickland AH; Ferguson T; Rodríguez J; Kröning H; Wolf I; Ganju V; Walpole E; Boucher E; Tichler T; Shacham-Shmueli E; Powell A; Eliadis P; Isaacs R; Price D; Moeslein F; Taieb J; Bower G; Gebski V; Van Buskirk M; Cade DN; Thurston K; Gibbs P J Clin Oncol; 2016 May; 34(15):1723-31. PubMed ID: 26903575 [TBL] [Abstract][Full Text] [Related]
10. The Post-SIR-Spheres Surgery Study (P4S): Retrospective Analysis of Safety Following Hepatic Resection or Transplantation in Patients Previously Treated with Selective Internal Radiation Therapy with Yttrium-90 Resin Microspheres. Pardo F; Sangro B; Lee RC; Manas D; Jeyarajah R; Donckier V; Maleux G; Pinna AD; Bester L; Morris DL; Iannitti D; Chow PK; Stubbs R; Gow PJ; Masi G; Fisher KT; Lau WY; Kouladouros K; Katsanos G; Ercolani G; Rotellar F; Bilbao JI; Schoen M Ann Surg Oncol; 2017 Sep; 24(9):2465-2473. PubMed ID: 28653161 [TBL] [Abstract][Full Text] [Related]
12. Yttrium-90 microsphere-selective internal radiation therapy with chemotherapy (chemo-SIRT) for colorectal cancer liver metastases: an in vivo double-arm-controlled phase II trial. Gulec SA; Pennington K; Wheeler J; Barot TC; Suthar RR; Hall M; Schwartzentruber D Am J Clin Oncol; 2013 Oct; 36(5):455-60. PubMed ID: 22643569 [TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of selective internal radiotherapy with yttrium-90 resin microspheres compared with sorafenib in locally advanced and inoperable hepatocellular carcinoma (SARAH): an open-label randomised controlled phase 3 trial. Vilgrain V; Pereira H; Assenat E; Guiu B; Ilonca AD; Pageaux GP; Sibert A; Bouattour M; Lebtahi R; Allaham W; Barraud H; Laurent V; Mathias E; Bronowicki JP; Tasu JP; Perdrisot R; Silvain C; Gerolami R; Mundler O; Seitz JF; Vidal V; Aubé C; Oberti F; Couturier O; Brenot-Rossi I; Raoul JL; Sarran A; Costentin C; Itti E; Luciani A; Adam R; Lewin M; Samuel D; Ronot M; Dinut A; Castera L; Chatellier G; Lancet Oncol; 2017 Dec; 18(12):1624-1636. PubMed ID: 29107679 [TBL] [Abstract][Full Text] [Related]
14. Radioembolization of liver metastases from colorectal cancer using yttrium-90 microspheres with concomitant systemic oxaliplatin, fluorouracil, and leucovorin chemotherapy. Sharma RA; Van Hazel GA; Morgan B; Berry DP; Blanshard K; Price D; Bower G; Shannon JA; Gibbs P; Steward WP J Clin Oncol; 2007 Mar; 25(9):1099-106. PubMed ID: 17369573 [TBL] [Abstract][Full Text] [Related]
15. Secondary technical resectability of colorectal cancer liver metastases after chemotherapy with or without selective internal radiotherapy in the randomized SIRFLOX trial. Garlipp B; Gibbs P; Van Hazel GA; Jeyarajah R; Martin RCG; Bruns CJ; Lang H; Manas DM; Ettorre GM; Pardo F; Donckier V; Benckert C; van Gulik TM; Goéré D; Schoen M; Pratschke J; Bechstein WO; de la Cuesta AM; Adeyemi S; Ricke J; Seidensticker M Br J Surg; 2019 Dec; 106(13):1837-1846. PubMed ID: 31424576 [TBL] [Abstract][Full Text] [Related]
16. Selective Internal Radiation Therapy (SIRT) for liver metastases secondary to colorectal adenocarcinoma. Welsh JS; Kennedy AS; Thomadsen B Int J Radiat Oncol Biol Phys; 2006; 66(2 Suppl):S62-73. PubMed ID: 16979443 [TBL] [Abstract][Full Text] [Related]
17. Postoperative hepatic arterial chemotherapy in high-risk patients as adjuvant treatment after resection of colorectal liver metastases - a randomized phase II/III trial - PACHA-01 (NCT02494973). Goéré D; Pignon JP; Gelli M; Elias D; Benhaim L; Deschamps F; Caramella C; Boige V; Ducreux M; de Baere T; Malka D BMC Cancer; 2018 Aug; 18(1):787. PubMed ID: 30081865 [TBL] [Abstract][Full Text] [Related]
18. Complete eradication of hepatic metastasis from colorectal cancer by Yttrium-90 SIRT. Garrean S; Muhs A; Bui JT; Blend MJ; Owens C; Helton WS; Espat NJ World J Gastroenterol; 2007 Jun; 13(21):3016-9. PubMed ID: 17589957 [TBL] [Abstract][Full Text] [Related]
19. Pretreatment tumor volume as a prognostic factor in metastatic colorectal cancer treated with selective internal radiation to the liver using yttrium-90 resin microspheres. Bhooshan N; Sharma NK; Badiyan S; Kaiser A; Moeslein FM; Kwok Y; Amin PP; Kudryasheva S; Chuong MD J Gastrointest Oncol; 2016 Dec; 7(6):931-937. PubMed ID: 28078116 [TBL] [Abstract][Full Text] [Related]
20. Treatment options for unresectable HCC with a focus on SIRT with Yttrium-90 resin microspheres. Wang EA; Stein JP; Bellavia RJ; Broadwell SR Int J Clin Pract; 2017 Nov; 71(11):. PubMed ID: 28758319 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]